Document is current
Any future updates will be listed below
-
Authors
van der Sar, Esmée C. A. http://orcid.org/0000-0003-4406-2409
Braat, Arthur J. A. T.
van der Voort- van Zyp, Jochem R. N.
van der Veen, Betty S.
van Leeuwen, Pim J.
de Vries-Huizing, Daphne M. V.
Hendrikx, Jeroen M. A.
Lam, Marnix G. E. H.
Vogel, Wouter V.
- License Information
-
More Information
Article History
Received: 21 April 2022
Accepted: 8 March 2023
First Online: 23 March 2023
Declarations
:
: The study has been approved by the Ethics Committee of the Netherlands Cancer Institute (NL75976.031.21).
: Not applicable.
: ML has acted as consultant for Boston Scientific and Terumo/Quirem Medical, and receives research support by Novartis/AAA, Boston Scientific and Terumo/Quirem Medical. AB has acted as consultant for Boston Scientific and Terumo/Quirem Medical. WV receives research support by Novartis/AAA. All other authors declare that they have no conflicts of interest. The study is supported by Advanced Accelerator Applications International S.A. Geneva, Switzerland, with supply of [<sup>177</sup>Lu]Lu-PSMA-617 free of charge and an unrestricted research grant to support data management and monitoring.
